BioSpace News Archive

Investigators from US Oncology Research, The US Oncology Network, and OntadaTM will share results from more than 30 studies exploring areas such as diffuse large B cell lymphoma, non-Hodgkin lymphoma, multiple myeloma and hematological adverse event management in the community oncology setting at the 63rd American Society of Hematology Annual Meeting and Exposition.

Scientific Industries, Inc. (OTCQB:SCND), a life sciences tool provider and developer of digitally simplified bioprocessing products, today announced that Scientific Bioprocessing, Inc. (SBI) has formed a unique partnership with BioMADE to bring state-of-the-art equipment and transformational learning experiences to college students across the United States.

Rising application of cellular health screening in personalized medicine, increasing global geriatric population, and growing awareness about cellular biomarkers are key factors driving market growth.

Rising prevalence of coronary artery disease and increasing technological advancements in cardiovascular diagnostics are key factors driving market growth.

Ambrx Biopharma Inc., or Ambrx, (NYSE: AMAM), today announced that NovoCodex Pharmaceuticals Ltd. (NovoCodex), Ambrx’s partner in China, presented positive safety and efficacy data from its ongoing ACE-Breast-01 Phase 1 clinical study of ARX788 at the San Antonio Breast Cancer Symposium (SABCS).

Increasing demand for therapeutics with high purity, rising production of generic drugs, and growing adoption of track etched membrane in food and beverage industry are key factors driving market growth.

NRx Pharmaceuticals (NASDAQ: NRXP) today announced the conclusion of high-level meetings in Hungary that are expected to lead to utilization of ZYESAMI® (aviptadil) in that country and the pivotal clinical trial of the BriLife COVID-19 vaccine (BriLife).

Scilex Holding Company announces highly significant positive top-line results from its Phase 3 SP-102 (SEMDEXA™) Pivotal Trial C.L.E.A.R Program for its novel, non-opioid, corticosteroid formulation, injectable dexamethasone sodium phosphate viscous gel product for the treatment of lumbosacral radicular pain (sciatica).

Allergan, an AbbVie (NYSE: ABBV) company, today announced that VUITY™ (pilocarpine HCl ophthalmic solution) 1.25%, the first and only eye drop approved by the U.S. Food and Drug Administration (FDA) to treat presbyopia, is now available by prescription in pharmacies nationwide.

The American Cancer Society has awarded nearly $3.9 million in funding to 77 health systems across the country to alleviate the financial burden of lodging costs for cancer patients.